Market Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Research Institute Study is First to Show Improved Medication Adherence and Health Outcomes for Generic Statins

[PR Newswire] – WOONSOCKET, R.I., Sept. 15, 2014 /PRNewswire/ — A new study by researchers at CVS Health (CVS) and Brigham and Women’s Hospital published today in the Annals of Internal Medicine, is . . . → Read More: Market Update: CVS Caremark Corporation (NYSE:CVS) – CVS Health Research Institute Study is First to Show Improved Medication Adherence and Health Outcomes for Generic Statins Similar Articles: Company Update: CVS Caremark Corporation (NYSE:CVS) – CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount Market Update: CVS Caremark Corporation (NYSE:CVS) – CVS Caremark Corporation Announces Cash Tender Offers for its 6.250% Senior Notes due 2027, 6.125% Senior Notes due 2039, 5.750% Senior Notes due 2041 and 5.750% Senior Notes due 2017 CVS Caremark Corporation (NYSE:CVS) | Study Commissioned by CVS Caremark Highlights Opportunities to Significantly Reduce Spending on Costly Specialty Medications